The EU-funded micro2MACRO (m2M) project, launched in December 2024, aims to advance tissue regeneration through an innovative bioprinting platform. m2M focuses on precisely patterning cell aggregates and microtissues into stable, customizable grafts that remodel into functional tissues after implantation. The project unites leading academic institutions,…
Lakestar leads round with participation from existing investors Bessemer Venture Partners and 83North Vertice, the spend optimization platform, today announced $50 million in Series C funding led by Lakestar. This investment brings the total raised to over $100 million. Additional participants include Perpetual Growth and CF…
SMART Technologies and the University of Melbourne s collaborative research promise impactful ways to engage neurodivergent students. SMART Technologies, a global leader in interactive education technology, has partnered with the University of Melbourne to launch the first-of-its-kind research initiative exploring how classroom environments can better support…
- Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period for the Broermann Medical Innovation Award…
SEATTLE, WA, Jan 6, 2025 - (ACN Newswire) - Spectral Capital Corporation (OTCQB: FCCN), a pioneer in Quantum as a Service (QaaS) computing and decentralized cloud infrastructure, is pleased to announce the achievement of a major patent milestone as the first step in its plan…
![Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma](https://www.so-co-it.com/wp-content/themes/socoit20/timthumb.php?src=wp-content%2Fuploads%2F716035.jpg&q=90&w=460&h=260&zc=1%20width=460%20height=260)
Back to media releases (https://norgine.com/media) Next media release (https://norgine.com/press_release/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia/) Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, i…
Infosys and Siemens AG to Accelerate Digital Learning with Generative AI
Collaboration provides lifelong learners at Siemens with new and personalized learning experiences Infosys (https://www.infosys.com/) (NSE: INFY)…
Infosys and Saïd Business School Launch Course for Entrepreneurs on Infosys Springboard
Collaboration aims to empower entrepreneurs and SMEs with the skills needed to thrive in today…
Infosys and Street Child Unite to Enable Access to Quality Education in Ukraine with Digital Innovation
Establish seven Digital Learning Centers and create high-quality content for teachers and children, available through…
CO.DON GmbH partners in EU-Funded Project to Advance 3D Bioprinting for Tissue Regeneration
The EU-funded micro2MACRO (m2M) project, launched in December 2024, aims to advance tissue regeneration through…
Nomination period for the Broermann Medical Innovation Award started
- Prize money of one million euros higher than the prize money for the…
TANAKA Group Company EEJA to Exhibit at 39th NEPCON JAPAN
Premiering new products in the field of plating technologies and processes to help meet rising…
Recent Comments